Evidence map›Paper›PMID 36237878›Full record

ArticleNagoya journal of medical science2022

<Editors' Choice> Multicenter survey for carbapenemase-producing Enterobacterales in central Japan.

Yuki Hara, Mitsutaka Iguchi, Nobuyuki Tetsuka, Hiroshi Morioka, Aki Hirabayashi, Masato Suzuki, Yuka Tomita, Keisuke Oka, Tetsuya Yagi

Open access · greenAbstract read
In one paragraph

Article in Nagoya journal of medical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuki HaraDepartment of Infectious Diseases, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Mitsutaka IguchiDepartment of Infectious diseases, Nagoya University Hospital, Nagoya, Japan.
Nobuyuki TetsukaDepartment of Infection control, Gifu University Graduate School of Medicine, Gifu, Japan.
Hiroshi MoriokaDepartment of Infectious diseases, Nagoya University Hospital, Nagoya, Japan.
Aki HirabayashiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Masato SuzukiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Yuka TomitaDepartment of Infection control, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
Keisuke OkaDepartment of Infectious diseases, Nagoya University Hospital, Nagoya, Japan.
Tetsuya YagiDepartment of Infectious Diseases, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nagoya University · JPNational Institute of Infectious Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenemase-producing Enterobacterales (CPE) raise concerns about the treatment options for infectious diseases and infection control. We conducted a multicenter study to clarify the molecular epidemiology of CPE in the Aichi Prefecture during the first 3-month period from 2015 to 2019. Carbapenemase production was screened using a modified carbapenem inactivation method, and the genotypes of the carbapenemase genes were determined by polymerase chain reaction sequencing. Genetic relatedness was analyzed using multilocus sequence typing (MLST). Twenty-four hospitals participated in this study. Of the 56,494 Enterobacterales strains detected during the study period, 341 (0.6%) that met the susceptibility criteria were analyzed. Sixty-five of the 341 strains were determined to be CPE, with an incidence rate of 0.12% (65/56,494). The bacterial species responsible for CPE were

Indexed as

carbapenemase-producing Enterobacterales (CPE)carbapenem-resistant Enterobacterales (CRE)molecular epidemiologymulticenter survey

Identifiers

PMID36237878
PMCPMC9529634
OpenAlexW4306247850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.